CD7 and acute lymphoblastic leukemia: Taken together, these data further refine the markers that identify LIC in NOTCH1Mutated T-ALL samples, and demonstrate that the CD34+CD2+CD7+ population is sensitive to and depleted following hN1 mAb treatment.